ADILNA Trademark

Trademark Overview


On Monday, July 11, 2005, a trademark application was filed for ADILNA with the United States Patent and Trademark Office. The USPTO has given the ADILNA trademark a serial number of 79016579. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, July 12, 2015. This trademark is owned by ADILNA ILAÇ SANAYI VE TICARET ANONIM SIRKETI. The ADILNA trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS, SKELETO-MUSCULAR DISORDERS, GENERAL INFECTIONS, VIRAL INFECTIONS, CENTRAL NERVOUS SYSTEM DISORDERS, GASTRO-INTESTINAL DISORDERS, FUNGAL DISEASES, ERECTILE DYSFUNCTION, RESPIRATORY DISEASES, ALLERGY, OPHTHALMIC DISEASES, CONTAINING ONE OR MORE OF THE FOLLOWING ACTIVE INGREDIENTS - CROMOLIN SODIUM, AMLODIPIN BESYLATE, ALENDRONATE SODIUM, CHLORAZEPATE DIPOTASSIUM, ATROPINE SULPHATE, ATORVASTATIN CALCIUM, CANUESARTAN CILEXETIL, CEFTRIAXONE SODIUM, EPHEDRINE HCL, GUAIPHENESINE, ZAFIRLUKAST, DONEPEZIL HCL, DIFLUNISAL, DIPYRIDAMOLE, FAMOTIDINE, LOSARTAN POTASSIUM, HYDRO CHLOROTHIAZIDE, MELOXICAM, PHENYLEPRINE HCL, FEXOFENADINE HCL, INDAPAMIDE, SUIJFISOXAZOLE, CLOPIDOGREL, LANSOPRAZOLE, CLARITHROMYCIN, FLURBIPROFEN, NIMESULIDE, PANTOPRAZOLE, PARACETAMOLE, PILOCARPINE HCL, LISINOPRIL, PSEUDOEPHEDRINE HCL, CIPROFLOXACIN HCL, SERTRALINE HCL, CYCLOPENTOLATE HCL, DIHYDROERGOTOXINE METHANSULFONATE, TERBINAFINE, TIMOLOL MALEAT...
adilna

General Information


Serial Number79016579
Word MarkADILNA
Filing DateMonday, July 11, 2005
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, July 12, 2015
Registration Number3204166
Registration DateTuesday, January 30, 2007
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, November 14, 2006

Trademark Statements


Goods and ServicesPHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS, SKELETO-MUSCULAR DISORDERS, GENERAL INFECTIONS, VIRAL INFECTIONS, CENTRAL NERVOUS SYSTEM DISORDERS, GASTRO-INTESTINAL DISORDERS, FUNGAL DISEASES, ERECTILE DYSFUNCTION, RESPIRATORY DISEASES, ALLERGY, OPHTHALMIC DISEASES, CONTAINING ONE OR MORE OF THE FOLLOWING ACTIVE INGREDIENTS - CROMOLIN SODIUM, AMLODIPIN BESYLATE, ALENDRONATE SODIUM, CHLORAZEPATE DIPOTASSIUM, ATROPINE SULPHATE, ATORVASTATIN CALCIUM, CANUESARTAN CILEXETIL, CEFTRIAXONE SODIUM, EPHEDRINE HCL, GUAIPHENESINE, ZAFIRLUKAST, DONEPEZIL HCL, DIFLUNISAL, DIPYRIDAMOLE, FAMOTIDINE, LOSARTAN POTASSIUM, HYDRO CHLOROTHIAZIDE, MELOXICAM, PHENYLEPRINE HCL, FEXOFENADINE HCL, INDAPAMIDE, SUIJFISOXAZOLE, CLOPIDOGREL, LANSOPRAZOLE, CLARITHROMYCIN, FLURBIPROFEN, NIMESULIDE, PANTOPRAZOLE, PARACETAMOLE, PILOCARPINE HCL, LISINOPRIL, PSEUDOEPHEDRINE HCL, CIPROFLOXACIN HCL, SERTRALINE HCL, CYCLOPENTOLATE HCL, DIHYDROERGOTOXINE METHANSULFONATE, TERBINAFINE, TIMOLOL MALEATE, TIAMPHENICOL, AZITHROMYCIN, TENOXICAM, FLUCONAZOLE, DIGOXINE, TIOCONAZOLE, DIMENHYDRINATE, QUINIDINE ARABOGALACTANE SULPHATE, QUINIDINE PHENYIJETHYL BARBITURATE, DILTIAZEM HCL, BUSPIRONE HCL, AMIODARONE HCL, TRAZODONE, DIFLUPREDNATE, ENOXACIN, LACTULOSE, KETOROLAC, PENTOXIFYLLINE, VITAMIN E, CHLORHEXIDINE, CETRIMIDE, PROPYPHENAZONE, CAFFEINE, CETIRIZINE, PHENYLPROPANOLAMINE, ZOLPIDEM, BACAMPICILLIN HCL, ROXITHROMYCIN, SULTAMICILLIN TOSILATE, ACETYLSALICYLIC ACID, AMPICILLIN NA, SULBACTAM NA, SILDENAFIL CITRATE, AMBROXOL HCL, RIBAVIRIN, LORATADINE, ETODOLAC, OMEPRAZOLE, OXYBUTYNIN CHLORIDE, QUINIDINE SULPHATE, OLANZAPINE, RALOXIFEN, PIOGLITAZONE, MOXIFLOXACIN, ROSIGLITAZONE, SIBUTRAMIN, CARVEDILOL, MONTELUKAST, CITALOPRAM, GLICLAZIDE, CEFACLOR, EZETIMIBE, ROFECOXIB, QUETIAPINE FUMARATE, METFORMIN HCL, ACARBOSE, CHLORPHENIRAMINE MALEATE, NATEGLINIDE, LEFLUNOMIDE, VALSARTAN, CEFAZOLIN SODIUM, DIACEREIN, PAROXETINE, LEVOFLOXACIN, LEVETIRACETAM, ZOLMITRIPTAN, GLIBENCLAMIDE, TIZANIDINE, PERINDOPRIL ERBUMINE, RAMIPRIL, CEFTAZIDIME, CEFUROXIME AXETYL, THIOCOLCHICOSIDE, ACAMPROSATE, ACETYLCYSTEINE, ALPHA CALCIDOL, ALPHA LIPOIC ACID, ARIPIPRAZOLE, ATOMOXETINE, BALSALAZIDE DISODIUM, BUTENAFINE HCL, CALCITRIOL, CARBONYL IRON, FOLIC ACID, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, CEFDINIR, CEFEPIME HCL, CEFIXIME, CEFPODOXIME PROXETIL, CEPPROZIL, CEPHALEXINE MONOHYDRATE, CICLESONIDE, CILAZAPRIL, CILOSTAZOL, CINITAPRIDE, CITICOLINE, CO-ENZYME Q10, DARIFENASIN, DEFERIPRONE, DOTHIEPIN, DULOXETINE, ELETRIPTAN, ESCITALOPRAM, ESOMEPRAZOLE, ETORICOXIB, FELODIPINE, FENOFIBRATE, FERROUS SULPHATE, ZINC SULPHATE, FLUVASTATIN, FROVATRIPTAN, GABAPENTIN, GALANTAMINE, GEMIFLOXACIN, GINKGO BILOBA, GLIMEPRIDE, GRANISETRON, IBANDRONATE, IRBESARTAN, IRON HYDROXIDE POLYMALTOSE, LAMIVUDINE, LAMOTRIGINE, LEVETIRACETAM, LETROZOLE, LINEZOLIDE, MEMANTINE HCL, METOPROLOL, MIDODRINE, MIRTAZAPINE, MIZOLASTINE, MOSAPRIDE CITRATE DIHYDRATE, MYCOPHENOLATE MOFETIL, NEBIVOLOL, NEFAZODONE, NIACIN, NITAZOXANIDE, ONDANSETRON, ORNIDAZOLE, OXCARBAZEPINE, PIMECROLIMTJS, PRAVASTATIN, PREGABALIN, RABEPRAZOL, REBAMIPIDE, REPAGLINIDE, RISEDRONATE, RISPERIDONE, RIVASTIGMINE, ROSUVASTATIN, SACCHAROMYCES BOULARDII, TACROLIMUS, TADALAFIL, TAMSULOSIN HCL, TAZAROTEN, TAZOBACTAM SODIUM, PIPERACILLIN SODIUM, TEGASEROD, TELITHROMYCIN, TERAZOCIN, TERIPARATIDE, TOLTERODINE TARTRATE, TOPIRAMATE, TRANDOLAPRIL, TRIMETHAZIDINE, VALACYCLOVIR, VALPROATE SODIUM, VENLAFAXINE, VORICONAZOLE, XIMELAGATRAN, ZALEPLON, ZIPRASIDONE, LEDRONIC ACID
Name/Portrait Description and/or Consent StatementThe mark ADILNA does not identify a living individual.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 27, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSANOVEL ILAÇ SANAYI VE TICARET ANONIM SIRKETI
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressTR

Party NameADILNA ILAÇ SANAYI VE TICARET ANONIM SIRKETI
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressTR

Party NameADILNA ILAÇ SANAYI VE TICARET ANONIM SIRKETI
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressTR

Party NameADILNA ILAÇ SANAYI VE TICARET ANONIM SIRKETI
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressTR

Trademark Events


Event DateEvent Description
Sunday, January 31, 2016NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sunday, January 31, 2016DEATH OF INTERNATIONAL REGISTRATION
Friday, June 5, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, November 6, 2014GENERIC MADRID TRANSACTION SENT TO IB
Thursday, November 6, 2014GENERIC MADRID TRANSACTION CREATED
Tuesday, May 27, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 27, 2013CANCELLED SECTION 71
Saturday, November 3, 2012CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, July 2, 2009CHANGE OF OWNER RECEIVED FROM IB
Friday, May 23, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, August 27, 2007FINAL DISPOSITION NOTICE SENT TO IB
Monday, August 27, 2007FINAL DISPOSITION PROCESSED
Tuesday, August 21, 2007FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 30, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, November 14, 2006PUBLISHED FOR OPPOSITION
Wednesday, October 25, 2006NOTICE OF PUBLICATION
Friday, September 22, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 15, 2006ASSIGNED TO LIE
Monday, September 4, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 17, 2006AMENDMENT FROM APPLICANT ENTERED
Monday, July 24, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 24, 2006PAPER RECEIVED
Friday, July 14, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 17, 2006REFUSAL PROCESSED BY IB
Tuesday, January 31, 2006NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, January 31, 2006NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, January 30, 2006NON-FINAL ACTION WRITTEN
Monday, January 30, 2006ASSIGNED TO EXAMINER
Monday, November 14, 2005NEW APPLICATION ENTERED IN TRAM
Thursday, November 10, 2005SN ASSIGNED FOR SECT 66A APPL FROM IB